Syros Pharmaceuticals

Syros Pharmaceuticals, Inc. is a biopharmaceutical company that pioneers the understanding of gene control in activating and repressing genomic regions. Their goal is to advance a new wave of medicines to address genetic diseases. They have built a proprietary gene control platform designed to systematically and efficiently analyze the unexplored regions of human disease tissue DNA to identify and link new drug targets to genomically defined patient populations.